logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Noninferiority Testing in Clinical Trials: Issues and Challenges 1st edition Tie-hua Ng

  • SKU: BELL-4946070
Noninferiority Testing in Clinical Trials: Issues and Challenges 1st edition Tie-hua Ng
$ 31.00 $ 45.00 (-31%)

4.4

42 reviews

Noninferiority Testing in Clinical Trials: Issues and Challenges 1st edition Tie-hua Ng instant download after payment.

Publisher: Chapman and Hall/CRC
File Extension: PDF
File size: 1.67 MB
Pages: 208
Author: Tie-Hua Ng
ISBN: 9781466561496, 1466561491
Language: English
Year: 2014
Edition: 1

Product desciption

Noninferiority Testing in Clinical Trials: Issues and Challenges 1st edition Tie-hua Ng by Tie-hua Ng 9781466561496, 1466561491 instant download after payment.

Take Your NI Trial to the Next Level

Reflecting the vast research on noninferiority (NI) designs from the past 15 years, Noninferiority Testing in Clinical Trials: Issues and Challenges explains how to choose the NI margin as a small fraction of the therapeutic effect of the active control in a clinical trial. Requiring no prior knowledge of NI testing, the book is easily accessible to both statisticians and nonstatisticians involved in drug development.

With over 20 years of experience in this area, the author introduces the basic elements of the NI trials one at a time in a logical order. He discusses issues with estimating the effect size based on historical placebo control trials of the active control. The book covers fundamental concepts related to NI trials, such as assay sensitivity, constancy assumption, discounting, and preservation. It also describes patient populations, three-arm trials, and the equivalence of three or more groups.

Related Products